Wyniki wyszukiwania - BazTech

Ograniczanie wyników

1 LogForum

1 2024

Powiadomienia systemowe

Sesja wygasła!

Znaleziono wyników: 1

Liczba wyników na stronie

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych: towary farmaceutyczne

Sortuj według:

Ogranicz wyniki do:

Cold supply chain finance - diagnosis, challenges, solutions

Bal Monika, Pawlicka Kinga

LogForum

2024

Vol. 20, no. 4

545--556

Background: The research problem addressed in this article is to determine the challenges in the field of cold supply chain finance. The cold supply chain covers all processes related to the storage, transportation and distribution of products that require low temperatures. Complex infrastructure, including cold stores, warehouses and transport vehicles, must be adapted to store and transport products at low temperatures, which can generate high logistics costs. Therefore, there is a need to optimize supply chain finances. Financial management in the cold supply chain area constitutes a research gap, given the limited number of verified publications on this topic. Based on the theory of supply chain finance (SCF) and cold supply chain (CSC), this study aims to examine the challenges that may arise in the financial management of cold supply chains. Although numerous publications on CSC in the pharmaceutical industry and supply chain finance exist, there is a research gap in combining these two areas. Methods: A thematic literature review complemented by an expert interview with an international pharmaceutical company - a leader in supply chain management - and the analytical induction method were used. These methods will help determine the specificity of applying SCF in cold supply chains. Results: This study presents generalizations regarding cold supply chain finance. The article extends the literature by reviewing these practices and by enabling research on best practices, as well as assessing a commonly accepted model for managing financial supply chain challenges. Although the study presents an in-depth assessment of cold supply chain finance practices, its limitations arise from the inability to compare the collected results with those from other companies. This is due to the small number of multinational pharmaceutical companies and the general reluctance to share financial or supplier information with the scientific sector. Conclusion: There is a very high, yet untapped, potential for using a wide range of SCF solutions to improve both operational and investment activities, as well as strategic ones (such as mutual capital investments of contractors). Effective financial management in CSC requires partnerships and advanced technology, particularly in pharmaceutical companies with numerous suppliers. It is also recommended to create departments responsible for supply chain finance and categorize suppliers into key groups.